已收盘 05-15 16:00:00 美东时间
+0.280
+0.30%
The 2026 Space Symposium features speakers from Palantir, L3Harris, Lockheed Martin, Redwire, Planet Labs and more.
04-14 02:58
今日重点评级关注:Leerink Partners:维持Camp4 Therapeutics"跑赢大市"评级,目标价从8美元升至9美元;韦德布什:维持Arcus Biosciences"跑赢大市"评级,目标价从37美元升至41美元
04-06 16:27
Citigroup analyst John Godyn maintains Science Applications Intl (NASDAQ:SAIC) with a Buy and lowers the price target from $133 to $120.
04-03 00:38
今日重点评级关注:韦德布什:维持Black Diamond Therapeutic"跑赢大市"评级,目标价从13美元升至14美元;花旗:维持Olema Pharmaceuticals"买入"评级,目标价从60美元升至62美元
03-18 10:48
SAIC reported mixed Q4 earnings, with sales down 5% to $1.75B but adjusted EPS beating estimates. Lowered outlook for 2027 but reaffirmed revenue guidance.
03-18 00:15
Stifel analyst Jonathan Siegmann maintains Science Applications Intl (NASDAQ:SAIC) with a Buy and lowers the price target from $128 to $120.
03-17 21:59
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据SAIC业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **第四季度业绩(FY2026 Q4):** - 营收:17.5亿美元,有机收入同比下降6% - 调整后EBITDA:1.81亿美元,利润率10.3% - 调整后摊薄每股收益:2.62美元 - 自由现金流:3.36亿美元 **全年业绩(FY2026):** - 营收:72.6亿美元,有机收入同比下降3% - 调整后EBITDA利润率:9.7% - 调整后摊薄每股收益:10.75美元 - 自由现金流:5.77亿美元 ## 2. 财务指标变化 **营收变化:** - Q4有机收入下降
03-17 12:28
Science Applications International Corp. (($SAIC)) has held its Q4 earnings cal...
03-17 08:08
SAIC (NASDAQ: SAIC) posts Q4 results and lowers FY27 EPS outlook. Get the details on revenue guidance, margins, and the $22.6B backlog.
03-17 01:59
华盛资讯3月17日讯,科学应用公布2026财年年度业绩,公司年度营收72.62亿美元,同比下降2.9%,归母净利润3.58亿美元,同比下滑1.1%。
03-17 00:47